|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 598.72 USD | +0.87% |
|
+1.91% | +22.88% |
| 31/10 | United Therapeutics Insider Sold Shares Worth $5,650,415, According to a Recent SEC Filing | MT |
| 29/10 | United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing | MT |
| Market Cap | 2.57TCr 2.3TCr 2.12TCr 1.92TCr 3.58TCr 2,43800Cr 3.65TCr 25TCr 10TCr 1,28300Cr 9.64TCr 9.43TCr 4,04500Cr | P/E 2026 * |
22.5x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.27TCr 2.04TCr 1.87TCr 1.7TCr 3.17TCr 2,15800Cr 3.23TCr 22TCr 8.96TCr 1,13500Cr 8.53TCr 8.35TCr 3,58000Cr | EV / Sales 2026 * |
7.15x | EV / Sales 2027 * | 5.95x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Xetra
| UTH | Delayed | |
|
Tradegate
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Berne S.E.
| UTH | End-of-day quote |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.87% | ||
| 1 week | +1.91% | ||
| 1 month | +10.49% | ||
| 3 months | +15.65% | ||
| 6 months | +4.79% | ||
| Current year | +22.88% |
| 1 week | 581.88 |  | 609.99 |
| 1 month | 523.95 | | 609.99 |
| Current year | 455.63 | | 609.99 |
| 1 year | 430.02 | | 609.99 |
| 3 years | 208.62 | | 609.99 |
| 5 years | 158.38 | | 609.99 |
| 10 years | 74.31 | | 609.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% | ||
| 15/10/26 | Exercice | General Counsel | 24,900 | 0.0581% | ||
| 14/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +1.91% | +34.41% | +168.65% | 2.57TCr | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,26300Cr | |
| -0.73% | +3.56% | +44.65% | +84.17% | 66TCr | |
| +1.41% | +3.24% | +35.25% | +108.88% | 52TCr | |
| +0.42% | +3.20% | +55.81% | +72.50% | 39TCr | |
| +2.18% | +2.93% | +73.90% | +45.59% | 37TCr | |
| +1.12% | +4.52% | +34.76% | +58.24% | 31TCr | |
| +6.96% | +8.86% | +11.95% | +36.20% | 29TCr | |
| +1.15% | +6.09% | +56.15% | +82.25% | 25TCr | |
| +3.06% | +9.38% | +42.48% | +117.32% | 21TCr | |
| Average | +1.96% | +5.50% | +45.37% | +92.97% | 42.88TCr | |
| Weighted average by Cap. | +2.00% | +6.57% | +50.41% | +100.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 317.82Cr 284.64Cr 261.83Cr 237.24Cr 443.45Cr 30TCr 451.75Cr 3.12TCr 1.25TCr 16TCr 1.19TCr 1.17TCr 50TCr | 360.49Cr 322.86Cr 296.98Cr 269.08Cr 502.99Cr 34TCr 512.4Cr 3.54TCr 1.42TCr 18TCr 1.35TCr 1.32TCr 57TCr |
| Net income | 121.65Cr 108.95Cr 100.22Cr 91Cr 169.74Cr 12TCr 172.92Cr 1.2TCr 479.76Cr 6.08TCr 456.55Cr 446.84Cr 19TCr | 141.1Cr 126.37Cr 116.24Cr 105.33Cr 196.88Cr 13TCr 200.56Cr 1.39TCr 556.47Cr 7.05TCr 529.55Cr 518.29Cr 22TCr |
| Net Debt | -295.05Cr -264.25Cr -243.07Cr -220.24Cr -411.68Cr -28TCr -419.39Cr -2.9TCr -1.16TCr -15TCr -1.11TCr -1.08TCr -46TCr | -422.93Cr -378.78Cr -348.42Cr -315.69Cr -590.11Cr -40TCr -601.16Cr -4.15TCr -1.67TCr -21TCr -1.59TCr -1.55TCr -67TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $598.72 | +0.87% | 5,18,240 |
| 29/26/29 | $593.54 | +1.20% | 3,70,341 |
| 28/26/28 | $586.48 | -0.80% | 4,21,674 |
| 27/26/27 | $591.20 | -0.28% | 4,57,446 |
| 26/26/26 | $592.84 | +0.91% | 5,77,007 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
